Physician profile
Timothy Cook
NPI 1659342038
$1,908.08
in general payments reported to CMS, 2019-2025
12 companies · $908 in 2025
The $908 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10.80 · 2020: $92.14 · 2021: $439 · 2023: $198 · 2024: $260 · 2025: $908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $868 · Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $868.37 |
| Food and Beverage | $497.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,023.78 | 2021-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $416.95 | 2021-2025 | Xywav |
| Harmony Biosciences LLC | $158.08 | 2020-2024 | Wakix |
| Resmed Corp | $91.75 | 2021 | |
| 3b Medical, INC. | $76.15 | 2023 | Luna |
| Axsome Therapeutics, INC. | $59.87 | 2023-2024 | Sunosi |
| Lilly USA, LLC | $20.12 | 2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $17.86 | 2020 | |
| Eisai INC. | $16.79 | 2021 | |
| Paratek Pharmaceuticals, INC. | $15.93 | 2023 | Nuzyra |
| Actelion Pharmaceuticals US, INC. | $10.80 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.